Parkman Healthcare Partners’s CVRx CVRX Stock Holding History

Parkman Healthcare Partners’s Portfolio CVRX Stock Details CVRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.06M	Buy	429,507 +16,489	+4%	+$121K	0.42%	66
2025 Q4	$2.93M	Sell	413,018 -78,390	-16%	-$716K	0.28%	81
2025 Q3	$3.97M	Sell	491,408 -297,691	-38%	-$2.24M	0.41%	70
2025 Q2	$4.64M	Sell	789,099 -440,423	-36%	-$3.04M	0.53%	65
2025 Q1	$15M	Buy	1,229,522 +308,348	+33%	+$4.35M	1.78%	19
2024 Q4	$11.7M	Buy	921,174 +238,277	+35%	+$2.94M	1.55%	23
2024 Q3	$6.02M	Buy	682,897 +235,277	+53%	+$2.14M	0.77%	45
2024 Q2	$5.37M	Buy	447,620 +115,530	+35%	+$1.33M	0.72%	49
2024 Q1	$6.05M	Buy	332,090 +92,090	+38%	+$2.18M	0.74%	47
2023 Q4	$7.55M	Buy	240,000 +17,880	+8%	+$335K	1.06%	32
2023 Q3	$3.37M	Buy	222,120 +81,357	+58%	+$1.34M	0.62%	47
2023 Q2	$2.17M	Buy	+140,763	New	+$1.72M	0.38%	74

Other funds holding CVRX

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GSK plc London $599M AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Parkman Healthcare Partners's CVRX Position: Q1 2026 in Review

Parkman Healthcare Partners increased its CVRx (CVRX) stake by 4% in Q1 2026, buying an estimated $121K and bringing the position to 429,507 shares worth $4.06M. The position accounts for 0.42% of the portfolio, ranked #66.

Parkman Healthcare Partners first reported a position in CVRX in Q2 2023 and has held it in 12 quarters since. The position peaked at $15M in Q1 2025. 99 funds tracked by Wall St. Rank hold CVRX as of Q1 2026.

Parkman Healthcare Partners held 429,507 shares of CVRx worth $4.06M as of Q1 2026.
Parkman Healthcare Partners bought 16,489 CVRx shares in Q1 2026, an estimated $121K.
CVRx made up 0.42% of Parkman Healthcare Partners's portfolio in Q1 2026, its #66 holding.
Parkman Healthcare Partners first reported a position in CVRx in Q2 2023 and has held it in 12 quarters since.
Parkman Healthcare Partners's CVRx position peaked at $15M in Q1 2025.
99 funds tracked by Wall St. Rank held CVRx as of Q1 2026.

Based on Parkman Healthcare Partners's 13F filing for Q1 2026, filed 15 May 2026.